Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James S Butler

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Lung Cancer (Amsterdam, Netherlands)|March 9, 2010
Clinical outcomes in extracranial tumor sites and unusual toxicities with concurrent whole brain radiation (WBRT) and Erlotinib treatment in patients with non-small cell lung cancer (NSCLC) with brain metastasisInan Olmez, Bernadine R Donahue, James S Butler, et al.
American Journal of Hematology|January 6, 2015
Combination therapy with a Tmprss6 RNAi-therapeutic and the oral iron chelator deferiprone additively diminishes secondary iron overload in a mouse model of β-thalassemia intermediaPaul J Schmidt, Tim Racie, Mark Westerman, et al.
The Journal of Biological Chemistry|December 14, 2004
Bacteriophage P22 tail accessory factor GP26 is a long triple-stranded coiled-coilDewan Andrews, James S Butler, Jawdat Al-Bassam, et al.
American Journal of Hematology|March 3, 2018
RNAi-mediated reduction of hepatic Tmprss6 diminishes anemia and secondary iron overload in a splenectomized mouse model of β-thalassemia intermediaPaul J Schmidt, Kaifeng Liu, Gary Visner, et al.
Haematologica|November 27, 2014
A competitive enzyme-linked immunosorbent assay specific for murine hepcidin-1: correlation with hepatic mRNA expression in established and novel models of dysregulated iron homeostasisPatrick Gutschow, Paul J Schmidt, Huiling Han, et al.
The New England Journal of Medicine|October 24, 2024
CRISPR-Based Therapy for Hereditary AngioedemaDanny M Cohn, Padmalal Gurugama, Markus Magerl, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 10, 2017
Evaluation of GalNAc-siRNA Conjugate Activity in Pre-clinical Animal Models with Reduced Asialoglycoprotein Receptor ExpressionJennifer L S Willoughby, Amy Chan, Alfica Sehgal, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 2, 2016
Preclinical evaluation of RNAi as a treatment for transthyretin-mediated amyloidosisJames S Butler, Amy Chan, Susete Costelha, et al.
The New England Journal of Medicine|June 15, 2026
Lonvoguran Ziclumeran - In Vivo CRISPR Gene Editing in Hereditary AngioedemaDanny M Cohn, Padmalal Gurugama, Hilary J Longhurst, et al.
The New England Journal of Medicine|January 31, 2024
CRISPR-Cas9 In Vivo Gene Editing of <i>KLKB1</i> for Hereditary AngioedemaHilary J Longhurst, Karen Lindsay, Remy S Petersen, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Lung Cancer (Amsterdam, Netherlands)|March 9, 2010
Clinical outcomes in extracranial tumor sites and unusual toxicities with concurrent whole brain radiation (WBRT) and Erlotinib treatment in patients with non-small cell lung cancer (NSCLC) with brain metastasisInan Olmez, Bernadine R Donahue, James S Butler, et al.
American Journal of Hematology|January 6, 2015
Combination therapy with a Tmprss6 RNAi-therapeutic and the oral iron chelator deferiprone additively diminishes secondary iron overload in a mouse model of β-thalassemia intermediaPaul J Schmidt, Tim Racie, Mark Westerman, et al.
The Journal of Biological Chemistry|December 14, 2004
Bacteriophage P22 tail accessory factor GP26 is a long triple-stranded coiled-coilDewan Andrews, James S Butler, Jawdat Al-Bassam, et al.
American Journal of Hematology|March 3, 2018
RNAi-mediated reduction of hepatic Tmprss6 diminishes anemia and secondary iron overload in a splenectomized mouse model of β-thalassemia intermediaPaul J Schmidt, Kaifeng Liu, Gary Visner, et al.
Haematologica|November 27, 2014
A competitive enzyme-linked immunosorbent assay specific for murine hepcidin-1: correlation with hepatic mRNA expression in established and novel models of dysregulated iron homeostasisPatrick Gutschow, Paul J Schmidt, Huiling Han, et al.
The New England Journal of Medicine|October 24, 2024
CRISPR-Based Therapy for Hereditary AngioedemaDanny M Cohn, Padmalal Gurugama, Markus Magerl, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 10, 2017
Evaluation of GalNAc-siRNA Conjugate Activity in Pre-clinical Animal Models with Reduced Asialoglycoprotein Receptor ExpressionJennifer L S Willoughby, Amy Chan, Alfica Sehgal, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 2, 2016
Preclinical evaluation of RNAi as a treatment for transthyretin-mediated amyloidosisJames S Butler, Amy Chan, Susete Costelha, et al.
The New England Journal of Medicine|June 15, 2026
Lonvoguran Ziclumeran - In Vivo CRISPR Gene Editing in Hereditary AngioedemaDanny M Cohn, Padmalal Gurugama, Hilary J Longhurst, et al.
The New England Journal of Medicine|January 31, 2024
CRISPR-Cas9 In Vivo Gene Editing of <i>KLKB1</i> for Hereditary AngioedemaHilary J Longhurst, Karen Lindsay, Remy S Petersen, et al.
Pageof 3